Related references
Note: Only part of the references are listed.Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas
Miguel Gallardo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
A large-scale binding and functional map of human RNA-binding proteins
Eric L. Van Nostrand et al.
NATURE (2020)
Eμ and 3′RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas
Nour Ghazzaui et al.
BLOOD ADVANCES (2020)
Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1
Jian Zhang et al.
MOLECULAR CELL (2019)
Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis
Alexandra Ioana Cioroianu et al.
ANALYTICAL CELLULAR PATHOLOGY (2019)
Expression levels of hnRNP K and p21WAF1/CIP1 are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma
Wassiliki Daskalaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis
Nour Ghazzaui et al.
ONCOTARGET (2017)
Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene
Marcus Lefebure et al.
NATURE COMMUNICATIONS (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap
J. Jason Morton et al.
CANCER RESEARCH (2016)
Aberrant hnRNP K expression: All roads lead to cancer
Miguel Gallardo et al.
CELL CYCLE (2016)
RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation
Jayanth Kumar Palanichamy et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL
H. J. Lee et al.
BLOOD CANCER JOURNAL (2016)
Widespread RNA binding by chromatin-associated proteins
David G. Hendrickson et al.
GENOME BIOLOGY (2016)
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eunhee Kim et al.
CANCER CELL (2015)
hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies
Miguel Gallardo et al.
CANCER CELL (2015)
Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression
Fat-Moon Suk et al.
ONCOTARGET (2015)
Cap-Independent Translation in Hematological Malignancies
Emilie Horvilleur et al.
FRONTIERS IN ONCOLOGY (2015)
U2AF1 mutations alter splice site recognition in hematological malignancies
Janine O. Ilagan et al.
GENOME RESEARCH (2015)
Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression
Paola Barboro et al.
CANCER LETTERS (2014)
Downregulation of hnRNP K by RNAi inhibits growth of human lung carcinoma cells
Fengming Tang et al.
ONCOLOGY LETTERS (2014)
The tumour microenvironment in B cell lymphomas
David W. Scott et al.
NATURE REVIEWS CANCER (2014)
Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas
Monica Gostissa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1
Charusheila Ramkumar et al.
NATURE COMMUNICATIONS (2013)
Molecular programming of B cell memory
Michael McHeyzer-Williams et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Higher Expression of the Heterogeneous Nuclear Ribonucleoprotein K in Melanoma
Fushi Wen et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
James J. Manfredi
GENES & DEVELOPMENT (2010)
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia
Michael G. Kharas et al.
NATURE MEDICINE (2010)
MDM2-Dependent Downregulation of p21 and hnRNP K Provides a Switch between Apoptosis and Growth Arrest Induced by Pharmacologically Activated p53
Martin Enge et al.
CANCER CELL (2009)
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
Marta Chesi et al.
CANCER CELL (2008)
The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas
Yosef Refaeli et al.
PLOS BIOLOGY (2008)
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
J. Iqbal et al.
LEUKEMIA (2007)
Development of a murine model for blastoid variant mantle-cell lymphoma
Richard J. Ford et al.
BLOOD (2007)
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
Michael Hummel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
M Notari et al.
BLOOD (2006)
hnRNP K: An HDM2 target and transcriptional coactivator of p53 in response to DNA damage
A Moumen et al.
CELL (2005)
Internal ribosome entry segment-mediated translation during apoptosis:: the role of IRES-trans-acting factors
KA Spriggs et al.
CELL DEATH AND DIFFERENTIATION (2005)
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice
G Cattoretti et al.
CANCER CELL (2005)
VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia
A Egle et al.
BLOOD (2004)
Cooperative binding of the hnRNP K three KH domains to mRNA targets
A Paziewska et al.
FEBS LETTERS (2004)
HnRNP K: One protein multiple processes
K Bomsztyk et al.
BIOESSAYS (2004)
Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo
JR Evans et al.
ONCOGENE (2003)
Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K:: implications in the regulation of SRC1A transcription
SA Ritchie et al.
NUCLEIC ACIDS RESEARCH (2003)
Lymphoid malignancies: The dark side of B-cell differentiation
AL Shaffer et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function
M Mandal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Burkitt lymphoma in the mouse
AL Kovalchuk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma:: A novel mechanism of oncogene de-regulation
SA Chappell et al.
ONCOGENE (2000)
Share Paper
